Literature DB >> 12877355

Hepatic ischemia-reperfusion syndrome after partial liver resection (LR): hepatic venous oxygen saturation, enzyme pattern, reduced and oxidized glutathione, procalcitonin and interleukin-6.

Michael Kretzschmar1, Antie Krüger, Wulf Schirrmeister.   

Abstract

The hepatic ischemia-reperfusion syndrome was investigated in 28 patients undergoing elective partial liver resection with intraoperative occlusion of hepatic inflow (Pringle maneuver) using the technique of liver vein catheterization. Hepatic venous oxygen saturation (ShvO2) was monitored continuously up to 24 hours after surgery. Aspartate aminotransferase, glutamate dehydrogenase, gamma-glutamyl transpeptidase, pseudocholinesterase, alpha-glutathione S-transferase, reduced and oxidized glutathione, procalcitonine, and interleukin-6 were serially measured both before and after Pringle maneuver during the resection and postoperatively in arterial and/or hepatic venous blood. ShvO2 measurement demonstrated that peri- and postoperative management was suitable to maintain an optimal hepatic oxygen supply. As expected, we were able to demonstrate a typical enzyme pattern of postischemic liver injury. There was a distinct decrease of reduced glutathione levels both in arterial and hepatic venous plasma after LR accompanied by a strong increase in oxidized glutathione concentration during the phase of reperfusion. We observed increases in procalcitonin and interleukin-6 levels both in arterial and hepatic venous blood after declamping. Our data support the view that liver resection in man under conditions of inflow occlusion resulted in ischemic lesion of the liver (loss of glutathione synthesizing capacity with disturbance of protection against oxidative stress) and an additional impairment during reperfusion (liberation of reactive oxygen species, local and systemic inflammation reaction with cytokine production). Additionally, we found some evidence for the assumption that the liver has an export function for reduced glutathione into plasma in man.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12877355     DOI: 10.1078/0940-2993-00291

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  8 in total

1.  In vivo imaging of hepatic hemodynamics and light scattering property during ischemia-reperfusion in rats based on spectrocolorimetry.

Authors:  Sharmin Akter; Satoko Kawauchi; Shunichi Sato; Suefumi Aosasa; Junji Yamamoto; Izumi Nishidate
Journal:  Biomed Opt Express       Date:  2017-01-19       Impact factor: 3.732

2.  Ketamine does not inhibit interleukin-6 synthesis in hepatic resections requiring a temporary porto-arterial occlusion (Pringle manoeuvre): a controlled, prospective, randomized, double-blinded study.

Authors:  Francisco Carlos Bonofiglio; Ernesto P Molmenti; Eduardo de Santibañes
Journal:  HPB (Oxford)       Date:  2011-07-22       Impact factor: 3.647

Review 3.  Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery.

Authors:  Santhalingam Jegatheeswaran; Ajith K Siriwardena
Journal:  HPB (Oxford)       Date:  2011-02       Impact factor: 3.647

4.  JunD protects the liver from ischemia/reperfusion injury by dampening AP-1 transcriptional activation.

Authors:  Jennifer J Marden; Yulong Zhang; Fredrick D Oakley; Weihong Zhou; Meihui Luo; Hong Peng Jia; Paul B McCray; Moshe Yaniv; Jonathan B Weitzman; John F Engelhardt
Journal:  J Biol Chem       Date:  2008-01-08       Impact factor: 5.157

5.  Use of Pharmacologic Agents for Modulation of Ischaemia-Reperfusion Injury after Hepatectomy: A Questionnaire Study of the LiverMetSurvey International Registry of Hepatic Surgery Units.

Authors:  Santhalingam Jegatheeswaran; Saurabh Jamdar; Thomas Satyadas; Aali J Sheen; Rene Adam; Ajith K Siriwardena
Journal:  HPB Surg       Date:  2014-11-12

6.  Effect of Remote Ischaemic Preconditioning on Liver Injury in Patients Undergoing Major Hepatectomy for Colorectal Liver Metastasis: A Pilot Randomised Controlled Feasibility Trial.

Authors:  Sanjeev Kanoria; Francis P Robertson; Naimish N Mehta; Giuseppe Fusai; Dinesh Sharma; Brian R Davidson
Journal:  World J Surg       Date:  2017-05       Impact factor: 3.352

7.  Liver manipulation causes hepatocyte injury and precedes systemic inflammation in patients undergoing liver resection.

Authors:  Marcel C G van de Poll; Joep P M Derikx; Wim A Buurman; Wilbert H M Peters; Hennie M J Roelofs; Stephen J Wigmore; Cornelis Hc Dejong
Journal:  World J Surg       Date:  2007-10       Impact factor: 3.352

8.  Noninvasive quantification of oxygen saturation in the portal and hepatic veins in healthy mice and those with colorectal liver metastases using QSM MRI.

Authors:  Eoin Finnerty; Rajiv Ramasawmy; James O'Callaghan; John J Connell; Mark Lythgoe; Karin Shmueli; David L Thomas; Simon Walker-Samuel
Journal:  Magn Reson Med       Date:  2018-11-19       Impact factor: 4.668

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.